Abbreviated Breast MRI After Cancer Treatment

Completed

Conditions studied: Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

In brief

500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. status post primary breast cancer treated with breast conservation therapy 3 years prior to recruitment 2. negative DBT examination six months prior to recruitment 3. all breast densities 4. clinically asymptomatic - no palpable masses, focalthickening, or clinically significant discharge We will identify these patients EPIC database utilizing the date of their last mammogram. The patients will be sent a letter explaining the study and the opportunity to enroll in the study. Interested patients may contact our research coordinators by the phone number provided in the letter. The study recruitment information will also be shared with referring physicians. Physicians may also directly refer patients to the study.

Key facts

Study ID

NCT03664778

Run by

University of Pennsylvania

People needed

184

Starts

2018-09-07

Expected to finish

2025-09-30

Last updated by the study team

2026-01-13

Who can join

Age: 18 and older, up to 82. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Status post primary breast cancer (both invasive and DCIS) treated with breast conservation therapy at least three years prior to recruitment
• Negative DBT examination within six months prior to recruitment
• All breast densities
• Clinically asymptomatic - no palpable masses or focal thickening, etc.

You may not qualify if…

• Patients who are pregnant or lactating.
• Patients who have not had a mammogram (digital breast tomosynthesis) in the past 6 months.
• Patients who are unwilling or unable to provide written informed consent.
• Patients symptomatic for breast disease (e.g. experiencing discharge, lumps, etc.).
• Recent breast surgery in the past two years including breast enhancements (e.g. implants or injections) benign surgical biopsies.
• Patients who are unable to receive an MRI with Gadolinium contrast.
• Patients who have not had an MRI of the breast within the past year.

Where it is running

• UPenn — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.